Ex Parte CARMAN - Page 27



                    Appeal No. 1997-2510                                                                                                    
                    Application No. 07/868,539                                                                                              

                    illustrates the two IE-3 regions oriented in opposite directions.  Notwithstanding                                      
                    the examiner’s failure to clearly identify the evidence supporting his argument,                                        
                    the examiner finds (Answer, page 10) that “[h]ere, one of ordinary skill in the art                                     
                    would have found it obvious to decrease Vmw 175 binding by using the DNA with                                           
                    the sequence of 5’ … NATCGTCCACACGGNN  NNCCGTGTAAGGACGATN …                                                             
                    3’ to bind to the Vmw 175 protein….”                                                                                    
                            Appellant argues (Brief, pages 16-17) “Kaji teaches the use of single-                                          
                    stranded oligonucleotides that bind to viral mRNA … [t]he method would not                                              
                    work if double-stranded DNA were employed.”  As appellant emphasizes (id.), in                                          
                    contrast to the claimed invention, Kaji repeatedly states that compositions                                             
                    effective to inhibit viral replication are single stranded.  We remind the examiner,                                    
                    that in determining whether the claimed invention is obvious, a prior art reference                                     
                    must be read as a whole and consideration must be given where the reference                                             
                    teaches away, as it does in the case of Kaji, from the claimed invention.  Akzo                                         
                    N.V., Aramide Maatschappij v.o.f. v. United States Int’l Trade Comm’n, 808 F.2d                                         
                    1471, 1481, 1 USPQ2d 1241, 1246 (Fed. Cir. 1986).                                                                       
                            With regard to Everett, appellant argues (Brief, bridging paragraph, pages                                      
                    17-18) while “Everett teaches the nucleotide sequence requirements of a                                                 
                    transcription factor protein Vmw175, Everett provides no motivation for                                                 
                    synthesizing oligonucleotides containing self-complimentary regions….”                                                  






                                                                     27                                                                     



Page:  Previous  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  Next 

Last modified: November 3, 2007